These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 12437663
1. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia. Zeng W, Maciejewski JP, Chen G, Risitano AM, Kirby M, Kajigaya S, Young NS. Br J Haematol; 2002 Dec; 119(3):803-9. PubMed ID: 12437663 [Abstract] [Full Text] [Related]
3. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA). Li X, Xu F, He Q, Wu L, Zhang Z, Chang C. Intern Med; 2010 Dec; 49(14):1349-55. PubMed ID: 20647647 [Abstract] [Full Text] [Related]
4. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. Lancet; 2010 Dec; 364(9431):355-64. PubMed ID: 15276395 [Abstract] [Full Text] [Related]
5. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases. Plasilova M, Risitano A, Maciejewski JP. Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651 [Abstract] [Full Text] [Related]
10. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance]. Cui JX, Pei MF, Zhang GS, Xu M. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129 [Abstract] [Full Text] [Related]
16. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia. Manz CY, Dietrich PY, Schnuriger V, Nissen C, Wodnar-Filipowicz A. Blood Cells Mol Dis; 1997 Oct 15; 23(1):110-22. PubMed ID: 9215756 [Abstract] [Full Text] [Related]
17. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, Durrant S, Juji T. Immunology; 2000 Feb 15; 99(2):229-34. PubMed ID: 10692041 [Abstract] [Full Text] [Related]
18. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M. Hum Immunol; 2004 Nov 15; 65(11):1377-88. PubMed ID: 15556688 [Abstract] [Full Text] [Related]